New drug designed to prevent chronic migraines

The U-S Food and Drug Administration has approved a new drug said to be the first designed to prevent chronic migraines.

Aimovig is a monthly shot developed by American drug maker Amgen and drug giant Novartis AG, and will cost almost seven-thousand dollars a year without insurance.

Current prevention treatments include pills originally developed for epilepsy and other conditions and the wrinkle reducer Botox, but many patients abandon them because they don’t help much or cause serious side effects.

Posted in News & Sports

+ Follow Us

 

Upcoming Events

  1. Handmade and Vintage Market

    March 24 @ 10:00 am - 3:00 pm
  2. 42nd Annual Rockton Dinner

    March 28 @ 7:00 pm - April 6 @ 9:00 pm
  3. Eat and Drink Norfolk

    April 4 @ 5:00 pm - April 6 @ 10:00 pm
  4. Waterford Tricenturena Skating Club’s 50th Anniversary Golden Memories Carnival

    April 6 @ 2:00 pm - 7:00 pm
  5. St. Paul’s Church Easter Service

    April 7 @ 2:00 pm

+ On-Air & Shows